Transforming Biopharma by ZS

Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management system. ZS experts talk with Maria Whitman about how companies can get started.

Joe DePinto, McKesson’s head of cell and gene advanced therapies, is passionate about helping patients get access to these groundbreaking therapeutic interventions. Maria Whitman gets Joe’s perspective on the current state of cell and gene therapy.

Clinical trial sites play an important role in biopharma’s success. On this episode of Transforming Biopharma, Maria Whitman talks with Lauren Wall of the University of Chicago and Caroline Smith of Charter Research, on how pharma can forge successful partnerships with sites. They identify factors such as patient-centric trial design and the importance of understanding site challenges to improve the clinical trial process.

If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision. Maria Whitman talks with Juliana Crawford, EVP of emerging strategies at the AHA, to find out how the association is thinking about how policy, science and consumer education can fit together in a broad approach to solving healthcare problems.

Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing successful strategies and “exploration” of what they might build for the future. He also discusses the role of leaders in driving transformation and the potential of generative AI.